ABT-869 from ABBEXA LTD
Search, find, compare suppliers for ABT-869 products.
| Edit | |
|---|---|
| Product Name | ABT-869 |
| Description | ABT-869 is a small molecule which can act as a VEGFR/PDGFR family inhibitor. It is provided as a powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: AKT, mTOR, Necroptosis. This product may be interest in the following research areas and diseases: Cell death, Angiogenesis, Cancer, Obesity. Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. Purity > 98%. MW: 375.4 g/mol |
| Size | 5 mg, 25 mg, |
| Concentration | n/a |
| Applications | n/a |
| Other Names | ABT-869, 1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea, Linifanib, 796967-16-3 |
| Gene, Accession, CAS # | CAS: 796967-16-3 |
| Catalog # | abx182361 |
| Price | please inquire |
| Order / More Info | ABT-869 from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD